Clinical Trial Update: Ii-HANC Improving Incurable Head and Neck Cancer Healthcare Experiences

View source ↗

Summary

This entry reports the completion of the Ii-HANC trial, which aims to improve healthcare experiences for patients with incurable head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Head and Neck Cancer | Status: COMPLETED